FDA Inspection
Northern Indiana Cancer Research Consortium IRBNorthern Indiana Cancer Research Consortium IRB – FDA Inspection, Feb 21, 2012
Record Details
This FDA Inspection record concerns Northern Indiana Cancer Research Consortium IRB, with an inspection on February 21, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 21, 2012
- Product Type
- Drugs
View Company Profile
ID · ec390355-4ab7-448f-9774-1391d4171ee2
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 771895
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 56.115(a)(2)Minutes of IRB meetings
- 21 CFR 56.108(a)(1)Initial and continuing reviews
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Northern Indiana Cancer Research Consortium IRB
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 5, 2013 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Northern Indiana Cancer Research Consortium IRB
- FDA Inspection 854295 - 2013-11-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.